ELQ S.A. (WSE:ELQ)

Inozyme Pharma Revenue

ELQ S.A. had revenue of 17.74M PLN in the quarter ending June 30, 2025, a decrease of -15.76%. This brings the company's revenue in the last twelve months to 72.14M, down -10.43% year-over-year. In the year 2024, ELQ S.A. had annual revenue of 74.30M, down -11.20%.

• Revenue (ttm): 72.14M
• Revenue Growth: -10.43%
• P/S Ratio: 4.38
• Revenue / Employee: 974.87K
• Employees: 61
• Market Cap: 316.00M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	74.30M	-9.37M	-11.20%
Dec 31, 2023	83.68M	55.31M	194.98%
Dec 31, 2022	28.37M	2.74M	10.70%
Dec 31, 2021	25.62M	-11.52M	-31.01%
Dec 31, 2020	37.14M	6.53M	21.34%